Cartesian Therapeutics, Inc. (RNAC:NASDAQ) closed at $6.18 on October 23, 2026, down 3.59% on the day. The stock trades 43.8% below its 52-week high of $11.00 and 10.4% above its 52-week low of $5.60. Over the past year, it lost 32.5%. Cartesian Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, RNAC closed higher on 111 days (44%). Its best day was March 9, 2026 (+31.68%) and its worst was March 5, 2026 (-12.58%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 1 time.
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.
Find more stocks like RNAC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.